comprehensive -WSS

comprehensive

author：Wikipedia 2025-10-03 00:04:20 - browse：77416

What’s a radiopharmaceutical? What does it mean to be Zepbound? And who’s to blame for a biotech blow-up?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. As so-called radiopharmaceuticals make headlines in oncology, we explore their fascinating scientific backstory and the biotech gold rush to make them. We also discuss the approval of Eli Lilly’s curiously named treatment for obesity, the latest implosion for a promising biotech company, and some news in the world of shareholder activism.

For more on what we cover, here’s the radiopharmaceuticals story; here’s the news on Lilly; here’s more on Ventyx Biosciences; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Rise in cancer among younger people worries and puzzles doctors

Wikipedia

WSS

Close Medicare's dangerous gaps in addiction treatment coverage

Q&A: Jennifer Adair on making gene therapy available globally

Cue Health's Covid

What causes rare myocarditis in young men after Covid vaccines?

Why rehabilitation engineers need to center patients in their research

Cholera vaccine supply gets boost as demand surges globally

Wikipedia

comprehensive

knowledge

Alkermes shareholders re

More tobacco lobbyists active in statehouses

Apple is now the first public company to be valued at $3 trillion

Roche’s Alnylam deal shows drug firms interested in heart drugs

In Memoriam: Notable people who died in 2023

Health care needs a new profession: neuroimaging counseling

Anesthesiologist group: stop taking Ozempic before surgery

MultiPlan and major insurers sued for alleged medical price

Dobbs anniversary: the lost opportunity of abortion as health care

The battle over 'scope creep' and who gets to be called 'doctor'

hotspot

Will the FTC rein in IQVIA's health data empire?

UHS says company favors patients whose insurance pays more

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

What to watch for from Zogenix and Amicus clinical trials

Biogen says it will cut costs by $700 million, slash 1,000 jobs

Device maker Teleflex to acquire urology company for $600M

entertainment

entertainment

Wikipedia

entertainment